Terms: = Colorectal cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Clinical Outcome
6 results:
1. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
[TBL] [Abstract] [Full Text] [Related]
2. Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
Volpato M; Perry SL; Marston G; Ingram N; Cockbain AJ; Burghel H; Mann J; Lowes D; Wilson E; Droop A; Randerson-Moor J; Coletta PL; Hull MA
Oncotarget; 2016 May; 7(19):28139-50. PubMed ID: 27058904
[TBL] [Abstract] [Full Text] [Related]
3. Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1.
Kim YS; Hwang SY; Kang HY; Sohn H; Oh S; Kim JY; Yoo JS; Kim YH; Kim CH; Jeon JH; Lee JM; Kang HA; Miyoshi E; Taniguchi N; Yoo HS; Ko JH
Mol Cell Proteomics; 2008 Jan; 7(1):1-14. PubMed ID: 17878270
[TBL] [Abstract] [Full Text] [Related]
4. clinical relevance of MMP-9, MMP-2, timp-1 and timp-2 in colorectal cancer.
Morán A; Iniesta P; García-Aranda C; De Juan C; Díaz-López A; Sánchez-Pernaute A; Torres AJ; Díaz-Rubio E; Balibrea JL; Benito M
Oncol Rep; 2005 Jan; 13(1):115-20. PubMed ID: 15583811
[TBL] [Abstract] [Full Text] [Related]
5. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract] [Full Text] [Related]
6. Increased matrix metalloproteinase 2 concentration and transcript expression in advanced colorectal carcinomas.
Chan CC; Menges M; Orzechowski HD; Orendain N; Pistorius G; Feifel G; Zeitz M; Stallmach A
Int J Colorectal Dis; 2001 Jun; 16(3):133-40. PubMed ID: 11459286
[TBL] [Abstract] [Full Text] [Related]
